mci-196 has been researched along with Hyperlipemia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aso, Y; Inukai, T; Matsumoto, S; Suetsugu, M; Takebayashi, K | 1 |
| Chiba, H; Fujii, S; Kishimoto, N; Sakuma, I; Tsutsui, H | 1 |
| Inagaki, K; Itoh, M; Kanayama, H; Katada, N; Kato, T; Sawai, Y | 1 |
| Abe, Y; Kushiya, F; Nakasaki, T; Nobori, T; Noda, M; Ooi, K; Sakaguchi, A; Sakurai, Y; Shiku, H; Tsukada, T; Wada, H | 1 |
| Kanai, S; Miyashita, Y; Oyama, T; Sasaki, H; Shirai, K | 1 |
| Babaya, N; Fujisawa, T; Hiromine, Y; Ikegami, H; Itoi-Babaya, M; Kawabata, Y; Kobayashi, M; Nojima, K; Noso, S; Ogihara, T; Shibata, M; Yamaji, K | 1 |
3 trial(s) available for mci-196 and Hyperlipemia
| Article | Year |
|---|---|
Effects of rosuvastatin and colestimide on metabolic parameters and urinary monocyte chemoattractant protein-1 in type 2 diabetic patients with hyperlipidemia.
Topics: C-Reactive Protein; Chemokine CCL2; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dinoprost; Enzyme-Linked Immunosorbent Assay; Epichlorohydrin; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Male; Middle Aged; Oxidative Stress; Peptide Fragments; Prospective Studies; Pyrimidines; Resins, Synthetic; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides | 2009 |
Comparison of efficacy of pitavastatin and colestimide in Japanese patients with diabetes mellitus complicated by hyperlipidemia and metabolic syndrome.
Topics: Adult; Aged; Albuminuria; Atherosclerosis; Biomarkers; C-Reactive Protein; Cholesterol, LDL; Diabetes Complications; Epichlorohydrin; Female; Glycated Hemoglobin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperglycemia; Hyperlipidemias; Hypolipidemic Agents; Imidazoles; Insulin Resistance; Japan; Male; Metabolic Syndrome; Middle Aged; Obesity; Quinolines; Resins, Synthetic; Triglycerides; Weight Loss | 2011 |
Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis.
Topics: Adult; Aged; Anion Exchange Resins; Atorvastatin; Electrophoresis, Agar Gel; Epichlorohydrin; Female; Hemostasis; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Imidazoles; Lipids; Lipoproteins; Male; Middle Aged; Pyrroles; Resins, Synthetic | 2005 |
3 other study(ies) available for mci-196 and Hyperlipemia
| Article | Year |
|---|---|
Colestimide, an anion exchange resin agent, can decrease the number of LDL particles without affecting their size in patients with hyperlipidemia.
Topics: Anion Exchange Resins; Apolipoproteins B; Epichlorohydrin; Female; Humans; Hyperlipidemias; Imidazoles; Lipoproteins, LDL; Magnetic Resonance Spectroscopy; Male; Middle Aged; Particle Size; Resins, Synthetic | 2010 |
Usefulness of preheparin lipoprotein lipase mass as a parameter for predicting the efficacy of colestimide.
Topics: Anion Exchange Resins; Body Weight; Cholesterol; Epichlorohydrin; Female; Humans; Hyperlipidemias; Imidazoles; Lipoprotein Lipase; Male; Middle Aged; Resins, Synthetic; Treatment Outcome; Triglycerides | 2005 |
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin.
Topics: Adipose Tissue; Animals; Anticholesteremic Agents; Blood Glucose; Body Weight; Carrier Proteins; Cholestyramine Resin; Diabetes Mellitus, Type 2; Disease Models, Animal; Epichlorohydrin; Fasting; Fatty Liver; Humans; Hyperlipidemias; Imidazoles; Insulin Resistance; Membrane Glycoproteins; Mice; Obesity; Resins, Synthetic; Weight Gain | 2007 |